These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20057515)

  • 1. Walkmycin B targets WalK (YycG), a histidine kinase essential for bacterial cell growth.
    Okada A; Igarashi M; Okajima T; Kinoshita N; Umekita M; Sawa R; Inoue K; Watanabe T; Doi A; Martin A; Quinn J; Nishimura Y; Utsumi R
    J Antibiot (Tokyo); 2010 Feb; 63(2):89-94. PubMed ID: 20057515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel antibacterial compounds specifically targeting the essential WalR response regulator.
    Gotoh Y; Doi A; Furuta E; Dubrac S; Ishizaki Y; Okada M; Igarashi M; Misawa N; Yoshikawa H; Okajima T; Msadek T; Utsumi R
    J Antibiot (Tokyo); 2010 Mar; 63(3):127-34. PubMed ID: 20111065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waldiomycin, a novel WalK-histidine kinase inhibitor from Streptomyces sp. MK844-mF10.
    Igarashi M; Watanabe T; Hashida T; Umekita M; Hatano M; Yanagida Y; Kino H; Kimura T; Kinoshita N; Inoue K; Sawa R; Nishimura Y; Utsumi R; Nomoto A
    J Antibiot (Tokyo); 2013 Aug; 66(8):459-64. PubMed ID: 23632918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of signermycin B, an antibiotic that targets the dimerization domain of histidine kinase WalK.
    Watanabe T; Igarashi M; Okajima T; Ishii E; Kino H; Hatano M; Sawa R; Umekita M; Kimura T; Okamoto S; Eguchi Y; Akamatsu Y; Utsumi R
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3657-63. PubMed ID: 22526318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus.
    Dubrac S; Boneca IG; Poupel O; Msadek T
    J Bacteriol; 2007 Nov; 189(22):8257-69. PubMed ID: 17827301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on in vivo effects of bacterial histidine kinase inhibitor, Waldiomycin, in Bacillus subtilis and Staphylococcus aureus.
    Fakhruzzaman M; Inukai Y; Yanagida Y; Kino H; Igarashi M; Eguchi Y; Utsumi R
    J Gen Appl Microbiol; 2015; 61(5):177-84. PubMed ID: 26582287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tearing down the wall: peptidoglycan metabolism and the WalK/WalR (YycG/YycF) essential two-component system.
    Dubrac S; Msadek T
    Adv Exp Med Biol; 2008; 631():214-28. PubMed ID: 18792692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of inhibitors of the essential histidine kinase, YycG in Bacillus subtilis and Staphylococcus aureus.
    Watanabe T; Hashimoto Y; Yamamoto K; Hirao K; Ishihama A; Hino M; Utsumi R
    J Antibiot (Tokyo); 2003 Dec; 56(12):1045-52. PubMed ID: 15015732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of H-box region mutants of WalK inert to the action of waldiomycin in Bacillus subtilis.
    Kato A; Ueda S; Oshima T; Inukai Y; Okajima T; Igarashi M; Eguchi Y; Utsumi R
    J Gen Appl Microbiol; 2017 Sep; 63(4):212-221. PubMed ID: 28674376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of MC21-B, an antibacterial compound produced by the marine bacterium Pseudoalteromonas phenolica O-BC30T.
    Isnansetyo A; Kamei Y
    Int J Antimicrob Agents; 2009 Aug; 34(2):131-5. PubMed ID: 19329285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an antivirulence drug against Streptococcus mutans: repression of biofilm formation, acid tolerance, and competence by a histidine kinase inhibitor, walkmycin C.
    Eguchi Y; Kubo N; Matsunaga H; Igarashi M; Utsumi R
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1475-84. PubMed ID: 21282451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway.
    Dubrac S; Bisicchia P; Devine KM; Msadek T
    Mol Microbiol; 2008 Dec; 70(6):1307-22. PubMed ID: 19019149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of the first essential two-component signal transduction system from Staphylococcus aureus and Streptococcus pneumoniae.
    Clausen VA; Bae W; Throup J; Burnham MK; Rosenberg M; Wallis NG
    J Mol Microbiol Biotechnol; 2003; 5(4):252-60. PubMed ID: 12867749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YycH regulates the activity of the essential YycFG two-component system in Bacillus subtilis.
    Szurmant H; Nelson K; Kim EJ; Perego M; Hoch JA
    J Bacteriol; 2005 Aug; 187(15):5419-26. PubMed ID: 16030236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kosinostatin, a major secondary metabolite isolated from the culture filtrate of Streptomyces violaceusniger strain HAL64.
    El-Naggar MY
    J Microbiol; 2007 Jun; 45(3):262-7. PubMed ID: 17618233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response regulator YycF essential for bacterial growth: X-ray crystal structure of the DNA-binding domain and its PhoB-like DNA recognition motif.
    Okajima T; Doi A; Okada A; Gotoh Y; Tanizawa K; Utsumi R
    FEBS Lett; 2008 Oct; 582(23-24):3434-8. PubMed ID: 18789936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activities of YycG histidine kinase inhibitors against Staphylococcus epidermidis biofilms.
    Qin Z; Lee B; Yang L; Zhang J; Yang X; Qu D; Jiang H; Molin S
    FEMS Microbiol Lett; 2007 Aug; 273(2):149-56. PubMed ID: 17578527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial agents that inhibit histidine protein kinase YycG of Bacillus subtilis.
    Yamamoto K; Kitayama T; Minagawa S; Watanabe T; Sawada S; Okamoto T; Utsumi R
    Biosci Biotechnol Biochem; 2001 Oct; 65(10):2306-10. PubMed ID: 11758928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NW-G01, a novel cyclic hexadepsipeptide antibiotic, produced by Streptomyces alboflavus 313: I. Taxonomy, fermentation, isolation, physicochemical properties and antibacterial activities.
    Guo Z; Shen L; Ji Z; Zhang J; Huang L; Wu W
    J Antibiot (Tokyo); 2009 Apr; 62(4):201-5. PubMed ID: 19265870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on terpenoids produced by actinomycetes: oxaloterpins A, B, C, D, and E, diterpenes from Streptomyces sp. KO-3988.
    Motohashi K; Ueno R; Sue M; Furihata K; Matsumoto T; Dairi T; Omura S; Seto H
    J Nat Prod; 2007 Nov; 70(11):1712-7. PubMed ID: 17970596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.